Locke Lord Represents Thalassa Holdings in £2.5m Investment in London Medical Laboratory

London Partner Sean Page represented Thalassa Holdings Ltd in a £2.5m investment in London Medical Laboratory Limited (LML). The financing will be used by LML to fund the opening of new phlebotomy clinical facilities and to increase the capacity of its existing facilities and has a term of three years. The financing is also a precursor to LML seeking a possible AIM Admission.
Posted on February 2, 2021